Arax Advisory Partners’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$30.3K Buy
+222
New +$27.3K ﹤0.01% 3669
2026
Q1
– Sell
-122
Closed -$20K – 4236
2025
Q4
$20K Buy
122
+41
+51% +$6.42K ﹤0.01% 2112
2025
Q3
$10.8K Buy
81
+29
+56% +$3.52K ﹤0.01% 2559
2025
Q2
$6.47K Buy
+52
New +$6.62K ﹤0.01% 2143
2022
Q2
– Sell
-18
Closed -$3K – 1221
2022
Q1
$3K Hold
18
– – ﹤0.01% 895
2021
Q4
$5K Hold
18
– – ﹤0.01% 775
2021
Q3
$5K Buy
+18
New +$4.62K ﹤0.01% 761

Other funds holding RGEN

Arax Advisory Partners's RGEN Position: Q2 2026 in Review

Arax Advisory Partners opened a new position in Repligen (RGEN) in Q2 2026: 222 shares worth $30.3K. The stake represents ﹤0.01% of the portfolio and ranks #3669 among its holdings. This is a return to the name: Arax Advisory Partners previously reported a position in RGEN as recently as Q4 2025.

Arax Advisory Partners first reported a position in RGEN in Q3 2021 and has held it in 7 quarters since. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Arax Advisory Partners held 222 shares of Repligen worth $30.3K as of Q2 2026.
  • Repligen was a new Arax Advisory Partners position in Q2 2026.
  • Repligen made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #3669 holding.
  • Arax Advisory Partners first reported a position in Repligen in Q3 2021 and has held it in 7 quarters since.
  • 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.